American guidelines for the management of gout as seen by general practitioners, Joint Bone Spine, 2012. ,
Management of gout by primary-care physicians and office-based rheumatologists in France in the early 21 st century-comparison with 2006 EULAR Recommendations, Joint Bone Spine, vol.3, pp.447-453, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01616224
EULAR Standing Committee for International Clinical Studies Including Therapeutics. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT), Ann Rheum Dis, vol.65, pp.1312-1336, 2006. ,
updated EULAR evidence-based recommendations for the management of gout, Ann Rheum Dis, vol.76, pp.29-42, 2016. ,
GOSPEL: prospective survey of gout in France. Part I: design and patient characteristics (n = 1003), Joint Bone Spine, vol.79, pp.464-70, 2012. ,
Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN), Nat Rev Rheumatol, vol.13, pp.561-568, 2017. ,
,
American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis, Arthritis Care Res(Hoboken), vol.64, pp.1447-61, 2012. ,
GOSPEL 2-Colchicine for the treatment of gout flares in France-a GOSPEL survey subgroup analysis. Doses used in common practices regardless of renal impairment and age, Joint Bone Spine, vol.83, issue.6, pp.687-693, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01282350
Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis, Ann Rheum Dis, vol.77, issue.7, pp.1048-1052, 2018. ,
From hyperuricaemia to gout: what are the missing links?, Nat Rev Rheumatol, vol.14, pp.448-457, 2018. ,
Gout: state of the art after a decade of developments. Rheumatology (Oxford), 2018. ,